PMC:7228307 / 5454-5746
Annnotations
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 59 | 33-40 | Gene | denotes | FcγRIIb | Gene:2213 |
| 63 | 67-79 | Species | denotes | participants | Tax:9606 |
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T34 | 287-291 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T18 | 87-90 | Disease | denotes | MOA | http://purl.obolibrary.org/obo/MONDO_0016702 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T64 | 13-15 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T65 | 16-18 | http://purl.obolibrary.org/obo/CLO_0008882 | denotes | Rs |
| T66 | 33-35 | http://purl.obolibrary.org/obo/CLO_0052676 | denotes | Fc |
| T67 | 159-160 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T68 | 228-229 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T69 | 264-265 | http://purl.obolibrary.org/obo/CLO_0001020 | denotes | a |
| T70 | 266-272 | http://purl.obolibrary.org/obo/SO_0000418 | denotes | signal |
| T71 | 287-291 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
LitCovid-sample-PD-IDO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 287-291 | http://purl.obolibrary.org/obo/CL_0000000 | denotes | cell |
LitCovid-sample-Pubtator
| Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
|---|---|---|---|---|---|
| 59 | 33-40 | Gene | denotes | FcγRIIb | Gene:2213 |
| 63 | 67-79 | Species | denotes | participants | Tax:9606 |
LitCovid-sample-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 0-292 | Sentence | denotes | In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell. |
LitCovid-sample-PD-FMA
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T34 | 287-291 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T29 | 0-292 | Sentence | denotes | In addition, FcγRs, particularly FcγRIIb (Figure 1e), are also key participants in the MOA of immune‐stimulating agonistic mAbs or apoptotic mAbs by acting as a scaffold for the additional cross‐linking of mAbs already bound to a cellular target, thereby inducing a signal in the target cell. |